WALTHAM, Mass.--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced the appointment of Kenneth I. Kaitin, Ph.D., to its board of directors effective November 7, 2007. This appointment further underscores Phase Forward’s continued commitment to develop and maintain a board with broad business experience and deep industry expertise. “Dr. Kaitin is a highly regarded expert on the dynamics of the drug development lifecycle,” said Bob Weiler, president and CEO of Phase Forward. “As Phase Forward continues to expand its electronic clinical data management product line, we look forward to his meaningful contributions to the company as a board member.”
